ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Enzymes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-10K12983
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Therapeutic Enzymes Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Enzymes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-10K12983
Report
July 2025
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BioMarin
AbbVie
Shire Plc
Alexion
Horizon Pharma
Allergan plc
Johnson & Johnson
Recordati Rare Diseases
VIVUS
Digestive Care
Leadiant Biosciences
Sanofi
Pfizer Inc

Therapeutic Enzymes Market Size

In 2024, the global market size of Therapeutic Enzymes was estimated to be worth US$ 9390 million and is forecast to reach approximately US$ 20660 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.

Therapeutic Enzymes Market

Therapeutic Enzymes Market

Therapeutic enzymes have a broad variety of specific uses, Oncolytics, Anticoagulants, Thrombolytics, Replacements for metabolic deficiencies, Digestive aids, Metabolic storage disorders, etc. Miscellaneous enzymes of diverse function.
Sanofi was the global greatest company in Therapeutic Enzymes industry, with the revenue market Share of 33% , followed by BioMarin, AbbVie , Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences.North America is the largest Therapeutic Enzymes market with about 70% market share. Europe is follower, accounting for about 21% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Enzymes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Enzymes.
The Therapeutic Enzymes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Enzymes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Enzymes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Therapeutic Enzymes Market Report

Report Metric Details
Report Name Therapeutic Enzymes Market
Forecasted market size in 2031 approximately US$ 20660 million
CAGR 12.1%
Forecasted years 2025 - 2031
Segment by Type
  • Injectable
  • Oral
  • Topical
Segment by Application
  • Gaucher Disease
  • MPS Disease
  • Gastrointestinal Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Therapeutic Enzymes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Therapeutic Enzymes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Enzymes sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Therapeutic Enzymes Market size in 2031?

Ans: The Therapeutic Enzymes Market size in 2031 will be approximately US$ 20660 million.

What is the Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences share in Therapeutic Enzymes Market?

Ans: Sanofi was the global greatest company in Therapeutic Enzymes industry, with the revenue market Share of 33% , followed by BioMarin, AbbVie , Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences.

What is the Therapeutic Enzymes Market share by region?

Ans: North America is the largest Therapeutic Enzymes market with about 70% market share. Europe is follower, accounting for about 21% market share.

Who are the main players in the Therapeutic Enzymes Market report?

Ans: The main players in the Therapeutic Enzymes Market are Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences

What are the Application segmentation covered in the Therapeutic Enzymes Market report?

Ans: The Applications covered in the Therapeutic Enzymes Market report are Gaucher Disease, MPS Disease, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the Therapeutic Enzymes Market report?

Ans: The Types covered in the Therapeutic Enzymes Market report are Injectable, Oral, Topical

1 Study Coverage
1.1 Therapeutic Enzymes Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Enzymes Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injectable
1.2.3 Oral
1.2.4 Topical
1.3 Market by Application
1.3.1 Global Therapeutic Enzymes Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Gaucher Disease
1.3.3 MPS Disease
1.3.4 Gastrointestinal Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic Enzymes Market Size Estimates and Forecasts
2.1.1 Global Therapeutic Enzymes Revenue 2020-2031
2.1.2 Global Therapeutic Enzymes Sales 2020-2031
2.2 Therapeutic Enzymes Market Size by Region: 2024 Versus 2031
2.3 Therapeutic Enzymes Sales by Region (2020-2031)
2.3.1 Global Therapeutic Enzymes Sales by Region: 2020-2025
2.3.2 Global Therapeutic Enzymes Sales Forecast by Region (2026-2031)
2.3.3 Global Therapeutic Enzymes Sales Market Share by Region (2020-2031)
2.4 Therapeutic Enzymes Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Therapeutic Enzymes Revenue by Region: 2020-2025
2.4.2 Global Therapeutic Enzymes Revenue Forecast by Region (2026-2031)
2.4.3 Global Therapeutic Enzymes Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Therapeutic Enzymes Sales by Type (2020-2031)
3.1.1.1 Global Therapeutic Enzymes Sales Volume by Type (2020-2031)
3.1.1.2 Global Therapeutic Enzymes Sales Market Share by Type (2020-2031)
3.1.2 Global Therapeutic Enzymes Revenue by Type (2020-2031)
3.1.2.1 Global Therapeutic Enzymes Revenue by Type (2020-2031)
3.1.2.2 Global Therapeutic Enzymes Revenue Market Share by Type (2020-2031)
3.1.3 Therapeutic Enzymes Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Therapeutic Enzymes Sales by Application (2020-2031)
3.2.1.1 Global Therapeutic Enzymes Sales Volume by Application (2020-2031)
3.2.1.2 Global Therapeutic Enzymes Sales Market Share by Application (2020-2031)
3.2.2 Global Therapeutic Enzymes Revenue by Application (2020-2031)
3.2.2.1 Global Therapeutic Enzymes Revenue by Application (2020-2031)
3.2.2.2 Global Therapeutic Enzymes Revenue Market Share by Application (2020-2031)
3.2.3 Therapeutic Enzymes Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injectable of Therapeutic Enzymes Revenue Market Share by Application
3.3.2 Oral of Therapeutic Enzymes Revenue Market Share by Application
3.3.3 Topical of Therapeutic Enzymes Revenue Market Share by Application
4 Global Therapeutic Enzymes by Manufacturers
4.1 Global Top Therapeutic Enzymes Manufacturers by Sales (2020-2025)
4.1.1 Global Therapeutic Enzymes Sales by Manufacturer (2020-2025)
4.1.2 Global Therapeutic Enzymes Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Therapeutic Enzymes Manufacturers by Revenue (2020-2025)
4.2.1 Global Therapeutic Enzymes Revenue by Manufacturer (2020-2025)
4.2.2 Global Therapeutic Enzymes Revenue Share by Manufacturer (2020-2025)
4.3 Global Therapeutic Enzymes Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Therapeutic Enzymes Manufacturers Covered: Ranking by Revenue
4.4.2 Global Therapeutic Enzymes Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Therapeutic Enzymes Manufacturing Base Distribution, Product Type
4.5.1 Therapeutic Enzymes Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Therapeutic Enzymes Market
4.5.3 Manufacturers Therapeutic Enzymes Product Type and Application
4.5.4 Injectable Market Sales of Therapeutic Enzymes by Manufacturer
4.5.5 Oral Market Sales of Therapeutic Enzymes by Manufacturer
4.5.6 Topical Market Sales of Therapeutic Enzymes by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Company Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Therapeutic Enzymes Products Offered
5.1.4 Sanofi Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Therapeutic Enzymes Sales by Product in 2024
5.1.6 Sanofi Therapeutic Enzymes Sales by Application in 2024
5.1.7 Sanofi Therapeutic Enzymes Sales by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 BioMarin
5.2.1 BioMarin Company Information
5.2.2 BioMarin Description, Business Overview
5.2.3 BioMarin Therapeutic Enzymes Products Offered
5.2.4 BioMarin Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.2.5 BioMarin Therapeutic Enzymes Sales by Product in 2024
5.2.6 BioMarin Therapeutic Enzymes Sales by Application in 2024
5.2.7 BioMarin Therapeutic Enzymes Sales by Geographic Area in 2024
5.2.8 BioMarin Recent Developments
5.3 AbbVie
5.3.1 AbbVie Company Information
5.3.2 AbbVie Description, Business Overview
5.3.3 AbbVie Therapeutic Enzymes Products Offered
5.3.4 AbbVie Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.3.5 AbbVie Therapeutic Enzymes Sales by Product in 2024
5.3.6 AbbVie Therapeutic Enzymes Sales by Application in 2024
5.3.7 AbbVie Therapeutic Enzymes Sales by Geographic Area in 2024
5.3.8 AbbVie Recent Developments
5.4 Shire
5.4.1 Shire Company Information
5.4.2 Shire Description, Business Overview
5.4.3 Shire Therapeutic Enzymes Products Offered
5.4.4 Shire Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Shire Therapeutic Enzymes Sales by Product in 2024
5.4.6 Shire Therapeutic Enzymes Sales by Application in 2024
5.4.7 Shire Therapeutic Enzymes Sales by Geographic Area in 2024
5.4.8 Shire Recent Developments
5.5 Alexion
5.5.1 Alexion Company Information
5.5.2 Alexion Description, Business Overview
5.5.3 Alexion Therapeutic Enzymes Products Offered
5.5.4 Alexion Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Alexion Therapeutic Enzymes Sales by Product in 2024
5.5.6 Alexion Therapeutic Enzymes Sales by Application in 2024
5.5.7 Alexion Therapeutic Enzymes Sales by Geographic Area in 2024
5.5.8 Alexion Recent Developments
5.6 Horizon Pharma
5.6.1 Horizon Pharma Company Information
5.6.2 Horizon Pharma Description, Business Overview
5.6.3 Horizon Pharma Therapeutic Enzymes Products Offered
5.6.4 Horizon Pharma Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Horizon Pharma Therapeutic Enzymes Sales by Product in 2024
5.6.6 Horizon Pharma Therapeutic Enzymes Sales by Application in 2024
5.6.7 Horizon Pharma Therapeutic Enzymes Sales by Geographic Area in 2024
5.6.8 Horizon Pharma Recent Developments
5.7 Allergan
5.7.1 Allergan Company Information
5.7.2 Allergan Description, Business Overview
5.7.3 Allergan Therapeutic Enzymes Products Offered
5.7.4 Allergan Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Allergan Therapeutic Enzymes Sales by Product in 2024
5.7.6 Allergan Therapeutic Enzymes Sales by Application in 2024
5.7.7 Allergan Therapeutic Enzymes Sales by Geographic Area in 2024
5.7.8 Allergan Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Company Information
5.8.2 Johnson & Johnson Description, Business Overview
5.8.3 Johnson & Johnson Therapeutic Enzymes Products Offered
5.8.4 Johnson & Johnson Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Johnson & Johnson Therapeutic Enzymes Sales by Product in 2024
5.8.6 Johnson & Johnson Therapeutic Enzymes Sales by Application in 2024
5.8.7 Johnson & Johnson Therapeutic Enzymes Sales by Geographic Area in 2024
5.8.8 Johnson & Johnson Recent Developments
5.9 Recordati Rare Diseases
5.9.1 Recordati Rare Diseases Company Information
5.9.2 Recordati Rare Diseases Description, Business Overview
5.9.3 Recordati Rare Diseases Therapeutic Enzymes Products Offered
5.9.4 Recordati Rare Diseases Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Recordati Rare Diseases Therapeutic Enzymes Sales by Product in 2024
5.9.6 Recordati Rare Diseases Therapeutic Enzymes Sales by Application in 2024
5.9.7 Recordati Rare Diseases Therapeutic Enzymes Sales by Geographic Area in 2024
5.9.8 Recordati Rare Diseases Recent Developments
5.10 Pfizer
5.10.1 Pfizer Company Information
5.10.2 Pfizer Description, Business Overview
5.10.3 Pfizer Therapeutic Enzymes Products Offered
5.10.4 Pfizer Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Pfizer Therapeutic Enzymes Sales by Product in 2024
5.10.6 Pfizer Therapeutic Enzymes Sales by Application in 2024
5.10.7 Pfizer Therapeutic Enzymes Sales by Geographic Area in 2024
5.10.8 Pfizer Recent Developments
5.11 Vivus
5.11.1 Vivus Company Information
5.11.2 Vivus Description, Business Overview
5.11.3 Vivus Therapeutic Enzymes Products Offered
5.11.4 Vivus Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Vivus Therapeutic Enzymes Sales by Product in 2024
5.11.6 Vivus Therapeutic Enzymes Sales by Application in 2024
5.11.7 Vivus Therapeutic Enzymes Sales by Geographic Area in 2024
5.11.8 Vivus Recent Developments
5.12 Digestive Care
5.12.1 Digestive Care Company Information
5.12.2 Digestive Care Description, Business Overview
5.12.3 Digestive Care Therapeutic Enzymes Products Offered
5.12.4 Digestive Care Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Digestive Care Therapeutic Enzymes Sales by Product in 2024
5.12.6 Digestive Care Therapeutic Enzymes Sales by Application in 2024
5.12.7 Digestive Care Therapeutic Enzymes Sales by Geographic Area in 2024
5.12.8 Digestive Care Recent Developments
5.13 Leadiant Biosciences
5.13.1 Leadiant Biosciences Company Information
5.13.2 Leadiant Biosciences Description, Business Overview
5.13.3 Leadiant Biosciences Therapeutic Enzymes Products Offered
5.13.4 Leadiant Biosciences Therapeutic Enzymes Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Leadiant Biosciences Therapeutic Enzymes Sales by Product in 2024
5.13.6 Leadiant Biosciences Therapeutic Enzymes Sales by Application in 2024
5.13.7 Leadiant Biosciences Therapeutic Enzymes Sales by Geographic Area in 2024
5.13.8 Leadiant Biosciences Recent Developments
6 North America
6.1 North America Therapeutic Enzymes Market Size YoY Growth 2020-2031
6.2 North America Therapeutic Enzymes Market Facts & Figures by Country
6.2.1 North America Therapeutic Enzymes Sales by Country (2020-2031)
6.2.2 North America Therapeutic Enzymes Revenue by Country (2020-2031)
6.3 North America Therapeutic Enzymes Sales by Type (2020-2025)
6.4 North America Therapeutic Enzymes Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Therapeutic Enzymes Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Therapeutic Enzymes Market Facts & Figures by Region
7.2.1 Asia-Pacific Therapeutic Enzymes Sales by Region (2020-2031)
7.2.2 Asia-Pacific Therapeutic Enzymes Revenue by Region (2020-2031)
7.3 Asia-Pacific Therapeutic Enzymes Sales by Type (2020-2025)
7.4 Asia-Pacific Therapeutic Enzymes Sales by Application (2020-2025)
8 Europe
8.1 Europe Therapeutic Enzymes Market Size YoY Growth 2020-2031
8.2 Europe Therapeutic Enzymes Market Facts & Figures by Country
8.2.1 Europe Therapeutic Enzymes Sales by Country (2020-2031)
8.2.2 Europe Therapeutic Enzymes Revenue by Country (2020-2031)
8.3 Europe Therapeutic Enzymes Sales by Type (2020-2025)
8.4 Europe Therapeutic Enzymes Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Therapeutic Enzymes Market Size YoY Growth 2020-2031
9.2 Latin America Therapeutic Enzymes Market Facts & Figures by Country
9.2.1 Latin America Therapeutic Enzymes Sales by Country (2020-2031)
9.2.2 Latin America Therapeutic Enzymes Revenue by Country (2020-2031)
9.3 Latin America Therapeutic Enzymes Sales by Type (2020-2025)
9.4 Latin America Therapeutic Enzymes Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Therapeutic Enzymes Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Therapeutic Enzymes Market Facts & Figures by Country
10.2.1 Middle East and Africa Therapeutic Enzymes Sales by Country (2020-2031)
10.2.2 Middle East and Africa Therapeutic Enzymes Revenue by Country (2020-2031)
10.3 Middle East and Africa Therapeutic Enzymes Sales by Type (2020-2025)
10.4 Middle East and Africa Therapeutic Enzymes Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Therapeutic Enzymes Supply Chain Analysis
11.2 Therapeutic Enzymes Key Raw Materials and Upstream Suppliers
11.3 Therapeutic Enzymes Clients Analysis
11.4 Therapeutic Enzymes Sales Channel and Sales Model Analysis
11.4.1 Therapeutic Enzymes Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Therapeutic Enzymes Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Therapeutic Enzymes Distributors
12 Therapeutic Enzymes Market Dynamics
12.1 Therapeutic Enzymes Industry Trends
12.2 Therapeutic Enzymes Market Drivers
12.3 Therapeutic Enzymes Market Challenges
12.4 Therapeutic Enzymes Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
BioMarin
AbbVie
Shire Plc
Alexion
Horizon Pharma
Allergan plc
Johnson & Johnson
Recordati Rare Diseases
VIVUS
Digestive Care
Leadiant Biosciences
Sanofi
Pfizer Inc
List of Tables
 Table 1. Global Therapeutic Enzymes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Therapeutic Enzymes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Therapeutic Enzymes Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Therapeutic Enzymes Sales by Region (2020-2025) & (K Units)
 Table 5. Global Therapeutic Enzymes Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Therapeutic Enzymes Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Therapeutic Enzymes Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Therapeutic Enzymes Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Therapeutic Enzymes Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Therapeutic Enzymes Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Therapeutic Enzymes Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Therapeutic Enzymes Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Therapeutic Enzymes Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Therapeutic Enzymes Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Therapeutic Enzymes Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Therapeutic Enzymes Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Therapeutic Enzymes Sales Share by Manufacturer (2020-2025)
 Table 18. Therapeutic Enzymes Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Therapeutic Enzymes Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Therapeutic Enzymes Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Therapeutic Enzymes Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Therapeutic Enzymes Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Therapeutic Enzymes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzymes as of 2024)
 Table 24. Therapeutic Enzymes Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Therapeutic Enzymes Market
 Table 26. Manufacturers Therapeutic Enzymes Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Sanofi Company Information
 Table 29. Sanofi Description and Business Overview
 Table 30. Sanofi Therapeutic Enzymes Product
 Table 31. Sanofi Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Sanofi Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 33. Sanofi Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 34. Sanofi Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 35. Sanofi Recent Developments
 Table 36. BioMarin Company Information
 Table 37. BioMarin Description and Business Overview
 Table 38. BioMarin Therapeutic Enzymes Product
 Table 39. BioMarin Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. BioMarin Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 41. BioMarin Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 42. BioMarin Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 43. BioMarin Recent Developments
 Table 44. AbbVie Company Information
 Table 45. AbbVie Description and Business Overview
 Table 46. AbbVie Therapeutic Enzymes Product
 Table 47. AbbVie Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. AbbVie Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 49. AbbVie Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 50. AbbVie Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 51. AbbVie Recent Developments
 Table 52. Shire Company Information
 Table 53. Shire Description and Business Overview
 Table 54. Shire Therapeutic Enzymes Product
 Table 55. Shire Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Shire Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 57. Shire Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 58. Shire Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 59. Shire Recent Developments
 Table 60. Alexion Company Information
 Table 61. Alexion Description and Business Overview
 Table 62. Alexion Therapeutic Enzymes Product
 Table 63. Alexion Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Alexion Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 65. Alexion Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 66. Alexion Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 67. Alexion Recent Developments
 Table 68. Horizon Pharma Company Information
 Table 69. Horizon Pharma Description and Business Overview
 Table 70. Horizon Pharma Therapeutic Enzymes Product
 Table 71. Horizon Pharma Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Horizon Pharma Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 73. Horizon Pharma Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 74. Horizon Pharma Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 75. Horizon Pharma Recent Developments
 Table 76. Allergan Company Information
 Table 77. Allergan Description and Business Overview
 Table 78. Allergan Therapeutic Enzymes Product
 Table 79. Allergan Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Allergan Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 81. Allergan Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 82. Allergan Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 83. Allergan Recent Developments
 Table 84. Johnson & Johnson Company Information
 Table 85. Johnson & Johnson Description and Business Overview
 Table 86. Johnson & Johnson Therapeutic Enzymes Product
 Table 87. Johnson & Johnson Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 89. Johnson & Johnson Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 90. Johnson & Johnson Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 91. Johnson & Johnson Recent Developments
 Table 92. Recordati Rare Diseases Company Information
 Table 93. Recordati Rare Diseases Description and Business Overview
 Table 94. Recordati Rare Diseases Therapeutic Enzymes Product
 Table 95. Recordati Rare Diseases Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Recordati Rare Diseases Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 97. Recordati Rare Diseases Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 98. Recordati Rare Diseases Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 99. Recordati Rare Diseases Recent Developments
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Therapeutic Enzymes Product
 Table 103. Pfizer Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Pfizer Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 105. Pfizer Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 106. Pfizer Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 107. Pfizer Recent Developments
 Table 108. Vivus Company Information
 Table 109. Vivus Description and Business Overview
 Table 110. Vivus Therapeutic Enzymes Product
 Table 111. Vivus Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Vivus Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 113. Vivus Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 114. Vivus Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 115. Vivus Recent Developments
 Table 116. Digestive Care Company Information
 Table 117. Digestive Care Description and Business Overview
 Table 118. Digestive Care Therapeutic Enzymes Product
 Table 119. Digestive Care Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. Digestive Care Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 121. Digestive Care Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 122. Digestive Care Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 123. Digestive Care Recent Developments
 Table 124. Leadiant Biosciences Company Information
 Table 125. Leadiant Biosciences Description and Business Overview
 Table 126. Leadiant Biosciences Therapeutic Enzymes Product
 Table 127. Leadiant Biosciences Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Leadiant Biosciences Sales Proportion of Therapeutic Enzymes by Product in 2024
 Table 129. Leadiant Biosciences Sales Proportion of Therapeutic Enzymes by Application in 2024
 Table 130. Leadiant Biosciences Sales Proportion of Therapeutic Enzymes by Geographic Area in 2024
 Table 131. Leadiant Biosciences Recent Developments
 Table 132. North America Therapeutic Enzymes Sales by Country (2020-2025) & (K Units)
 Table 133. North America Therapeutic Enzymes Sales by Country (2026-2031) & (K Units)
 Table 134. North America Therapeutic Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 135. North America Therapeutic Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 136. North America Therapeutic Enzymes Sales by Type (2020-2025) & (K Units)
 Table 137. North America Therapeutic Enzymes Sales by Application (2020-2025) & (K Units)
 Table 138. Asia-Pacific Therapeutic Enzymes Sales by Region (2020-2025) & (K Units)
 Table 139. Asia-Pacific Therapeutic Enzymes Sales by Region (2026-2031) & (K Units)
 Table 140. Asia-Pacific Therapeutic Enzymes Revenue by Region (2020-2025) & (US$ Million)
 Table 141. Asia-Pacific Therapeutic Enzymes Revenue by Region (2026-2031) & (US$ Million)
 Table 142. Asia-Pacific Therapeutic Enzymes Sales by Type (2020-2025) & (K Units)
 Table 143. Asia-Pacific Therapeutic Enzymes Sales by Application (2020-2025) & (K Units)
 Table 144. Europe Therapeutic Enzymes Sales by Country (2020-2025) & (K Units)
 Table 145. Europe Therapeutic Enzymes Sales by Country (2026-2031) & (K Units)
 Table 146. Europe Therapeutic Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 147. Europe Therapeutic Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 148. Europe Therapeutic Enzymes Sales by Type (2020-2025) & (K Units)
 Table 149. Europe Therapeutic Enzymes Sales by Application (2020-2025) & (K Units)
 Table 150. Latin America Therapeutic Enzymes Sales by Country (2020-2025) & (K Units)
 Table 151. Latin America Therapeutic Enzymes Sales by Country (2026-2031) & (K Units)
 Table 152. Latin America Therapeutic Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 153. Latin America Therapeutic Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 154. Latin America Therapeutic Enzymes Sales by Type (2020-2025) & (K Units)
 Table 155. Latin America Therapeutic Enzymes Sales by Application (2020-2025) & (K Units)
 Table 156. Middle East and Africa Therapeutic Enzymes Sales by Country (2020-2025) & (K Units)
 Table 157. Middle East and Africa Therapeutic Enzymes Sales by Country (2026-2031) & (K Units)
 Table 158. Middle East and Africa Therapeutic Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 159. Middle East and Africa Therapeutic Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 160. Middle East and Africa Therapeutic Enzymes Sales by Type (2020-2025) & (K Units)
 Table 161. Middle East and Africa Therapeutic Enzymes Sales by Application (2020-2025) & (K Units)
 Table 162. Therapeutic Enzymes Key Raw Materials, Industry Status and Trend
 Table 163. Therapeutic Enzymes Key Raw Materials and Upstream Suppliers
 Table 164. Therapeutic Enzymes Clients Status and Trend
 Table 165. Therapeutic Enzymes Typical Clients
 Table 166. Therapeutic Enzymes Distributors
 Table 167. Therapeutic Enzymes Market Trends
 Table 168. Therapeutic Enzymes Market Drivers
 Table 169. Therapeutic Enzymes Market Challenges
 Table 170. Therapeutic Enzymes Market Restraints
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Therapeutic Enzymes Product Picture
 Figure 2. Global Therapeutic Enzymes Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Therapeutic Enzymes Sales Market Share by Type in 2024 & 2031
 Figure 4. Injectable Product Picture
 Figure 5. Oral Product Picture
 Figure 6. Topical Product Picture
 Figure 7. Global Therapeutic Enzymes Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Therapeutic Enzymes Sales Market Share by Application in 2024 & 2031
 Figure 9. Gaucher Disease
 Figure 10. MPS Disease
 Figure 11. Gastrointestinal Diseases
 Figure 12. Others
 Figure 13. Therapeutic Enzymes Report Years Considered
 Figure 14. Global Therapeutic Enzymes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Therapeutic Enzymes Market Size 2020-2031 (US$ Million)
 Figure 16. Global Therapeutic Enzymes Sales 2020-2031 (K Units)
 Figure 17. Global Therapeutic Enzymes Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Therapeutic Enzymes Revenue Market Share by Region (2020-2031)
 Figure 19. Global Therapeutic Enzymes Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Therapeutic Enzymes Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Therapeutic Enzymes Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 22. Global Therapeutic Enzymes Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Therapeutic Enzymes Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Therapeutic Enzymes Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 25. Injectable of Therapeutic Enzymes Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Oral of Therapeutic Enzymes Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Topical of Therapeutic Enzymes Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Global Therapeutic Enzymes Sales Share by Manufacturer in 2024
 Figure 29. Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 30. Injectable Market Sales Proportion by Manufacturer in 2024
 Figure 31. Oral Market Sales Proportion by Manufacturer in 2024
 Figure 32. Topical Market Sales Proportion by Manufacturer in 2024
 Figure 33. North America Therapeutic Enzymes Revenue 2020-2031 (US$ Million)
 Figure 34. North America Therapeutic Enzymes Sales Market Share by Type (2020-2025)
 Figure 35. North America Therapeutic Enzymes Sales Market Share by Application (2020-2025)
 Figure 36. Asia-Pacific Therapeutic Enzymes Revenue 2020-2031 (US$ Million)
 Figure 37. Asia-Pacific Therapeutic Enzymes Sales Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Therapeutic Enzymes Revenue Market Share by Region (2020-2031)
 Figure 39. Asia-Pacific Therapeutic Enzymes Sales Market Share by Type (2020-2025)
 Figure 40. Asia-Pacific Therapeutic Enzymes Sales Market Share by Application (2020-2025)
 Figure 41. Europe Therapeutic Enzymes Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Europe Therapeutic Enzymes Sales Market Share by Country (2020-2031)
 Figure 43. Europe Therapeutic Enzymes Revenue Market Share by Country (2020-2031)
 Figure 44. Europe Therapeutic Enzymes Sales Market Share by Type (2020-2025)
 Figure 45. Europe Therapeutic Enzymes Sales Market Share by Application (2020-2025)
 Figure 46. Latin America Therapeutic Enzymes Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Latin America Therapeutic Enzymes Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Therapeutic Enzymes Revenue Market Share by Country (2020-2025)
 Figure 49. Latin America Therapeutic Enzymes Sales Market Share by Type (2020-2025)
 Figure 50. Latin America Therapeutic Enzymes Sales Market Share by Application (2020-2025)
 Figure 51. Middle East and Africa Therapeutic Enzymes Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Middle East and Africa Therapeutic Enzymes Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Therapeutic Enzymes Revenue Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Therapeutic Enzymes Sales Market Share by Type (2020-2025)
 Figure 55. Middle East and Africa Therapeutic Enzymes Sales Market Share by Application (2020-2025)
 Figure 56. Therapeutic Enzymes Supply Chain (Upstream and Downstream Market)
 Figure 57. Global Production Market Share of Therapeutic Enzymes Raw Materials by Region in 2024
 Figure 58. Therapeutic Enzymes Distribution Channels
 Figure 59. Global Therapeutic Enzymes Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 60. Global Therapeutic Enzymes Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Intraoperative Ultrasound Market Insights Forecast to 2030
Therapeutic Enzyme Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plants Specialty Source Enzymes Market Insights Forecast to 2030
Global Diagnostic Specialty Enzymes Market Insights Forecast to 2030
Global Microorganisms Source Specialty Enzymes Market Insights Forecast to 2030
Healthcare Specialty Enzymes Market
Medical Enzyme Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Special Enzyme Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enzyme Product Market Research Report 2025
Global Microbial Industrial Enzymes Market Research Report 2025
Global Liquid Bakery Enzyme Market Insights Forecast to 2030
Global Powdered Bakery Enzyme Market Insights Forecast to 2030
Global Medical Thrombolytic Enzyme Market Research Report 2024
Global Textiles Enzymes Market Insights Forecast to 2030
Global Myocardial Infarction Treatment Enzyme Market Research Report 2024
Medical Enzyme Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biofuel Renewable Energy Enzyme Market Research Report 2024
Global Energy Enzymes Market Research Report 2024
Global Fruit Enzyme Market Insights Forecast to 2030
Global Industrial Specialty Enzymes Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions